The American Journal of Medicine
Volume 122, Issue 2 , Pages 126-128, February 2009

Anticoagulation: A Pathway to Clinical Effectiveness

  • Geoffrey D. Barnes, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Geoffrey D. Barnes, MD, Cardiovascular Center, 1500 East Medical Center Drive, SPC 5853, Ann Arbor, MI 48109-5853
    • ,
  • James B. Froehlich, MD, MPH

University of Michigan Cardiovascular Center, Ann Arbor, Mich

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Kim A. Eagle, MD, Section Editor

 Conflict of Interest: Consulting: Pfizer, Sanofi-Aventis (JBF). Speaker's Bureau: Pfizer; Sanofi-Aventis; Merck/Shering-Plough (JBF). Research Grant: Blue-Cross/Blue Shield of Michigan; Novartis (JBF). None (GDB).

 Authorship: All authors had access to the data and a role in writing the article.

PII: S0002-9343(08)00982-0

doi:10.1016/j.amjmed.2008.10.002

The American Journal of Medicine
Volume 122, Issue 2 , Pages 126-128, February 2009

Article Tools